FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to neurology, and can be used for increasing a level of synaptic proteins in a nerve cell or a brain cell in a subject. That is ensured by introduction a combination of agents to the specified subject, namely omega-3 fatty acid and/or omega-6 fatty acid in a combination with uridine or choline salts.
EFFECT: versions of the method provide the increased level of synaptic proteins in the nerve cell, including the brain cell that can be used for correction of age-related memory disorders.
15 cl, 11 dwg, 7 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND DISORDERS, DISTURBED OR LOST MEMORY | 2011 |
|
RU2603470C2 |
| COMPOSITIONS CONTAINING PUFA AND/OR URIDINE, AND METHODS OF APPLICATION THEREOF | 2006 |
|
RU2429851C2 |
| METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY | 2013 |
|
RU2667968C2 |
| COMPOUNDS USED FOR SLEEP/WAKEFULNESS CYCLE NORMALISATION | 2003 |
|
RU2366428C2 |
| METHOD FOR IMPROVING BLADDER FUNCTION | 2016 |
|
RU2715247C2 |
| NUTRITIONAL COMPOSITION FOR IMPROVING CEREBRAL FUNCTION IN PHENYLKETONURIA | 2014 |
|
RU2690660C2 |
| NUTRITIVE PRODUCT FOR REDUCING PHENYLALANINE LEVELS IN THE PATIENTS WITH PKU | 2016 |
|
RU2740905C2 |
| LIQUID PRODUCT CONTAINING NUCLEOTIDES/NUCLEOSIDES | 2008 |
|
RU2446807C2 |
| METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2622999C2 |
| METHOD FOR NEUROTRAUMA TREATMENT | 2012 |
|
RU2749191C2 |
